Chapter 22.1
Paediatric Liver Diseases
Marianne Samyn,
Giorgina Mieli-Vergani,
Marianne Samyn
Search for more papers by this authorGiorgina Mieli-Vergani
Search for more papers by this authorMarianne Samyn,
Giorgina Mieli-Vergani,
Marianne Samyn
Search for more papers by this authorGiorgina Mieli-Vergani
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- McKiernan PJ (2002) Neonatal cholestasis. Semin Neonatol 7 (2), 153–165.
- Mieli-Vergani G Howard ER Portman B et al. (1989) Late referral for biliary atresia — missed opportunities for effective surgery. Lancet 1 (8635), 421–423.
-
Roberts EA
(2003)
Neonatal hepatitis syndrome.
Semin Neonato
18
(5),
357–374.
10.1016/S1084-2756(03)00093-9 Google Scholar
- Davenport M Savage M Mowat AP et al. (1993) Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery 113 (6), 662–668.
- Farrant P Meire HB Mieli-Vergani G (2000) Ultrasound features of the gall bladder in infants presenting with conjugated hyperbilirubi-naemia. Br J Radiol 73 (875), 1154–1158.
- Park WH Choi SO Lee HJ et al. (1997) A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Pediatr Surg 32 (11), 1555–1559.
- Davenport M De Ville GJ de Stringer MD et al. (2004) Seamless management of biliary atresia in England and Wales (1999–2002). Lancet 363 (9418), 1354–1357.
- McKiernan PJ Baker AJ Kelly DA (2000) The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 355 (9197), 25–29.
- Davenport M Kerkar N Mieli-Vergani G et al. (1997) Biliary atresia: the King's College Hospital experience (1974–1995). J Pediatr Surg 32 (3), 479–485.
- Hadzic N Davenport M Tizzard S et al. (2003) Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr 37 (4), 430–433.
- Redkar R Davenport M Howard ER (1998) Antenatal diagnosis of congenital anomalies of the biliary tract. J Pediatr Surg 33 (5), 700–704.
- Medee-Manesme O Bernard O Brunelle F et al. (1987) Sclerosing cholangitis with neonatal onset. J Pediatr 111 (2), 225–229.
- Debray D Pariente D Urvoas E et al. (1994) Sclerosing cholangitis in children. J Pediatr 124 (1), 49–56.
- Alagille D Odievre M Gautier M et al. (1975) Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 86 (1), 63–71.
- Kohsaka T Yuan ZR Guo SX et al. (2002) The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 36 (4 Pt 1), 904–912.
- Clayton RJ Iber FL Ruebner BH et al. (1969) Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 117 (1), 112–124.
- Bull LN van Eijk MJ Pawlikowska L et al. (1998) A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nature Genet 18 (3), 219–224.
- Strautnieks SS Bull LN Knisely AS et al. (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nature Genet 20 (3), 233–238.
- Jacquemin E Hermans D Myara A et al. (1997) Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25 (3), 519–523.
- Whitington PF Whitington GL (1988) Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 95 (1), 130–136.
- Dixon PH Weerasekera N Linton KJ et al. (2000) Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9 (8), 1209–1217.
- De Vree JM Ottenhoff R Bosma PJ et al. (2000) Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119 (6), 1720–1730.
- Kaufman SS (2002) Prevention of parenteral nutrition-associated liver disease in children. Pediatr Transplant 6 (1), 37–42.
- Francavilla R Castellaneta SP Hadzic N et al. (2000) Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paedi-atric liver transplantation. J Hepatol 32 (6), 986–992.
- Chang MH Chen TH Hsu HM et al. (2005) Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11 (21), 7953–7957.
- Chen HL Chang CJ Kong MS et al. (2004) Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39 (1), 58–63.
- D'Antiga L Aw M Atkins M et al. (2006) Combined lamivudine/interferon-alpha treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: a pilot study. J Pediatr 148 (2), 228–233.
- Dikici B Ozgenc F Kalayci AG et al. (2004) Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. J Gastroenterol Hepatol 19 (2), 127–133.
- Ozgenc F Dikici B Targan S et al. (2004) Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection. Antivir Ther 9 (1), 23–26.
- Saltik-Temizel IN Kocak N Demir H (2004) Interferon-alpha and lamivudine combination therapy of children with chronic hepatitis b infection who were interferon-alpha nonresponders. Pediatr Infect Dis J 23 (5), 466–468.
- Saltik-Temizel IN Kocak N Demir H (2005) Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection. J Clin Gastroenterol 39 (1), 68–70.
- Ceci O Margiotta M Marello F et al. (2001) High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind? J Hepatol 35 (5), 687–688.
- Fanning LJ (2002) The Irish paradigm on the natural progression of hepatitis C virus infection: an investigation in a homogeneous patient population infected with HCV 1b (review). Int J Mol Med 9 (2), 179–184.
- Wiese M Grungreiff K Guthoff W et al. (2005) Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany — a 25-year multicenter study. J Hepatol 43 (4), 590–598.
- Kelly D Skidmore S (2002) Hepatitis C-Z: recent advances. Arch Dis Child 86 (5), 339–343.
- Wirth S Pieper-Boustani H Lang T et al. (2005) Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 (5), 1013–1018.
- Gregorio GV Portmann B Reid F et al. (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25 (3), 541–547.
- Gregorio GV Portmann B Karani J et al. (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33 (3), 544–553.
- Martins da CC Baldwin D Portmann B et al. (1992) Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 15 (4), 609–615.
- Dhawan A Taylor RM Cheeseman P et al. (2005) Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 11 (4), 441–448.
- Kinnman N Lindblad A Housset C et al. (2000) Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32 (2), 334–340.
- Salvatore F Scudiero O Castaldo G (2002) Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 111 (1), 88–95.
- Lindblad A Glaumann H Strandvik B (1999) Natural history of liver disease in cystic fibrosis. Hepatology 30 (5), 1151–1158.
- Sheth S Shea JC Bishop MD et al. (2003) Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 113 (3), 286–292.
- Colombo C Battezzati PM Crosignani A et al. (2002) Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 36 (6), 1374–1382.
- Lamireau T Monnereau S Martin S et al. (2004) Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 41 (6), 920–925.
- Lindblad A Glaumann H Strandvik B (1998) A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 27 (1), 166–174.
- Fridell JA Bond GJ Mazariegos GV et al. (2003) Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg 38 (8), 1152–1156.
- Roberts EA (2002) Steatohepatitis in children. Best Pract Res Clin Gastroenterol 16 (5), 749–765.
- Lavine JE Schwimmer JB (2004) Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 8 (3), 549–558.
- Schwimmer JB Behling C Newbury R et al. (2005) Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (3), 641–649.
- Schwimmer JB Middleton MS Deutsch R et al. (2005) A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (7), 871–879.
- Desmet VJ (1992) Congenital diseases of intrahepatic bile ducts: variations on the theme ‘ductal plate malformation’. Hepatology 16 (4), 1069–1083.
- Jaeken J Matthijs G Saudubray JM et al. (1998) Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 62 (6), 1535–1539.
- Boyle MJ Doyle GD McNulty JG (1989) Monolobar Caroli's disease. Am J Gastroenterol 84 (11), 1437–1444.
- Trey C Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3, 282–298.
- Bhaduri BR Mieli-Vergani G (1996) Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 16 (4), 349–355.
- Dhawan A Mieli-Vergani G (2005) Acute liver failure in neonates. Early Hum Dev 81 (12), 1005–1010.
- Verma A Dhawan A Zuckerman M et al. (2006) Neonatal herpes simplex virus infection presenting as acute liver failure: prevalent role of herpes simplex virus type I. J Pediatr Gastroenterol Nutr 42 (3), 282–286.
- Whitington PF Hibbard JU (2004) High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364 (9446), 1690–1698.
- Rodrigues F Kallas M Nash R et al. (2005) Neonatal hemochromatosis — medical treatment vs. transplantation: the King's experience. Liver Transpl 11 (11), 1417–1424.
- O'Grady JG (1997) Paracetamol-induced acute liver failure: prevention and management. J Hepatol 26 (Suppl. 1), 41–46.
- Girlanda R Vilca-Melendez H Srinivasan P et al. (2005) Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure. Transplant Proc 37 (4), 1720–1721.
- Velazquez A Vela-Amieva M Ciceron-Arellano I et al. (2000) Diagnosis of inborn errors of metabolism. Arch Med Res 31 (2), 145–150.
- Bouchard G Laberge C Scriver CR (1985) [Hereditary tyrosinemia and vitamin-dependent rickets in Saguenay. A genetic and demographic approach]. Union Med Can 114 (8), 633–636.
- Kvittingen EA (1986) Hereditary tyrosinemia type I — an overview. Scand J Clin Lab Invest Suppl 184, 27–34.
- Holme E Lindstedt S (2000) Nontransplant treatment of tyrosinemia. Clin Liver Dis 4 (4), 805–814.
- Clayton PT (2002) Inborn errors presenting with liver dysfunction. Semin Neonatol 7 (1), 49–63.
- Cori GT Cori CF (1952) Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem 199 (2), 661–667.
- Chou JY Matern D Mansfield BC et al. (2002) Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2 (2), 121–143.
- Slonim AE Weisberg C Benke P et al. (1982) Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11 (4), 420–422.
- Moses SW Parvari R (2002) The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr Mol Med 2 (2), 177–188.
- Sokol RJ Treem WR (1999) Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 28 (1), 4–16.
- Dhawan A Mitry RR Hughes RD (2005) Hepatocyte transplantation for metabolic disorders, experience at King's College hospital and review of literature. Acta Gastroenterol Belg 68 (4), 457–460.
- Pinkel D (1993) Bone marrow transplantation in children. J Pediatr 122 (3), 331–341.
- Stocker JT (2006) Hepatic tumours in children. In: F Suchy, RJ Sokol, WF Balistreri, eds. Liver Disease in Children, 2nd edn, Philadelphia: Lippincott, Williams and Wilkins, p. 915.
- Ayling RM Davenport M Hadzic N et al. (2001) Hepatic hemangioendothelioma associated with production of humoral thyrotropin- Like factor. J Pediatr 138 (6), 932–935.
- Stringer MD Alizai NK (2005) Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 40 (11), 1681–1690.
- Reymond D Plaschkes J Luthy AR et al. (1995) Focal nodular hyperplasia of the liver in children: review of follow-up and outcome. J Pediatr Surg 30 (11), 1590–1593.
-
Saul SH
Titelbaum DS
Gansler TS et al.
(1987)
The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia.
Cancer
60
(12),
3049–3055.
10.1002/1097-0142(19871215)60:12<3049::AID-CNCR2820601232>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- Otte JB de Ville de GJ Reding R (2005) Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 9 (5), 557–565.
- Tiao GM Bobey N Allen S et al. (2005) The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146 (2), 204–211.
- Knisely AS Strautnieks SS Meier Y et al. (2006) Hepatocellular carcinoma in ten children under five years old with bile salt export pump deficiency. Hepatology 44, 474–486.
- Czauderna P Mackinlay G Perilongo G et al. (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 20 (12), 2798–2804.
- Sakai M Ikeda H Suzuki N et al. (2001) Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg 36 (4), 663–666.
- Molleston JP (2003) Variceal bleeding in children. J Pediatr Gastroenterol Nutr 37 (5), 538–545.
- Stringer MD Howard ER Mowat AP (1989) Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia. J Pediatr Surg 24 (5), 438–442.
- Howard ER Stringer MD Mowat AP (1988) Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices. Br J Surg 75 (5), 404–408.
- McKiernan PJ Beath SV Davison SM (2002) A prospective study of endoscopic esophageal variceal ligation using a multiband ligator. J Pediatr Gastroenterol Nutr 34 (2), 207–211.
- De Ville de GJ Alberti D Clapuyt P et al. (1998) Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extra-hepatic portal hypertension. J Pediatr Surg 33 (4), 597–601.
- Martin SR Atkison P Anand R et al. (2004) Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 8 (3), 273–283.
- Muiesan P Girlanda R Jassem W et al. (2005) Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg 242 (5), 732–738.
- Adam R McMaster P O'Grady JG et al. (2003) Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9 (12), 1231–1243.
- Girlanda R Vilca-Melendez H Srinivasan P et al. (2005) Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure. Transplant Proc 37 (4), 1720–1721.
- Aw MM Samaroo B Baker AJ et al. (2001) Calcineurin-inhibitor related nephrotoxicity — reversibility in paediatric liver transplant recipients. Transplantation 72 (4), 746–749.
- Verma A Wade JJ Cheeseman P et al. (2005) Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant 9 (2), 220–225.
- Al-Akash SI Al Makadma AS Al Omari MG (2005) Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy. Pediatr Transplant 9 (2), 249–253.
- Kerkar N Hadzic N Davies ET et al. (1998) De-novo autoimmune hepatitis after liver transplantation. Lancet 351 (9100), 409–413.
- Evans HM Kelly DA McKiernan PJ et al. (2006) Progressive histological damage in liver allografts following paediatric liver transplantation. Hepatoloty 43, 1109–1117.
